Selected publications
-
Traceback: A proposed framework to increase identification and genetic counseling of BRCA1 and BRCA2 mutation carriers through family-based outreach.
Journal of Clinical Oncology.
2017
Article
GET IT
Times cited: 17 -
Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus.
Breast Cancer Research.
2016
Academic Article
GET IT
Times cited: 11 -
Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk.
PLoS Genetics.
2013
Academic Article
GET IT
Times cited: 162 -
Challenges to the development of new agents for molecularly defined patient subsets: Lessons from BRCA1/2-associated breast cancer.
Journal of Clinical Oncology.
2011
Academic Article
GET IT
Times cited: 16 -
Current academic clinical trials in ovarian cancer: Gynecologic Cancer Intergroup and US National Cancer Institute Clinical Trials Planning Meeting, May 2009.
International Journal of Gynecological Cancer.
2010
Review
GET IT
Times cited: 7 -
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: A proof-of-concept trial.
The Lancet.
2010
Academic Article
GET IT
Times cited: 1195